There were 2,427 press releases posted in the last 24 hours and 441,512 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Five Prime Therapeutics and Zai Lab Announce Exclusive License Agreement for FPA144 Anti-FGFR2b Antibody in Greater China and Global Strategic Development Collaboration

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image